Development and characterization of gastroretentive mucoadhesive tablets of venlafaxine hydrochloride
Keywords:
Gastroretentive, Mucoadhesive, Venlafaxine hydrochloride, TabletAbstract
The present study was undertaken with an aim to formulation development and evaluation of gastroretentive mucoadhesive sustained release tablet of Venlafaxine hydrochloride which releases the drug in a sustained manner over a period of 12 hours, by using Carbopol 971P in combination with eudragit RS-PO and ethyl cellulose as a mucoadhesive and release retardant respectively. Preformulation study was done initially and results directed for the further course of formulation. Based on Preformulation studies different batches of Venlafaxine hydrochloride were prepared using Carbopol 971P, Eudragit RS-PO and ethyl cellulose chosen for their different hydrophilic properties to calculate the sustained release properties. Sustained release tablets were prepared by direct compression and were evaluated for bioadhesion time, swelling index and matrix erosion, and in vitro drug release. The tablets of batch F3 and F6 had high swelling behaviors but release of drug is very less. And batch F2 having considerable swelling index and in vitro drug release (99.85%). Batch F2 can be taken as an ideal or optimized formulation of sustained release tablets for 12 hour release as it fulfills all the requirements for sustained release tablet. From the discussion it is concluded that use of carbopol as a release retardant and adhesive polymer is very effective; and also it act as strong release retardant in combination with hydrophobic polymers.
References
Keith S. Advances in psychotropic formulations
Progress in Neuro Psychopharmacology &
Biological Psychiatry. 2006; 30: 996–1008.
Holliday SM, Benfield P. Venlafaxine: a review
of its pharmacology and therapeutic potential in
depression. Drugs 1995; 49: 280–294.
Makhija SM, Vavia PR. Once daily sustained
release tablets of venlafaxine, a novel
antidepressant, Euro J Pharma Biopharma 2002;
: 9–15.
Simona JS, Aguiar LM. Journal Extended-release
venlafaxine in relapse prevention for patients with
major depressive disorders, Journal of Psychiatric
Research 2004; 38: 249–257.
Kothawade PI, Zate SU, Gajbe JW, Rathi MN,
Yewale CP, Baheti DR. Design and Evaluation of
Sustained Release Matrix Tablet of Metformin
Hydrochloride. Research J. Pharm. Tech 2010; 3:
(In press).
Ansel HC. Pharmaceutical dosage forms and drug
delivery system. 8th ed. New Delhi. India: B.I.
Waverly Pvt. Ltd; 1995. p. 189-94, 235-36.
Staniforth J.N., Powder flow In: Aulton’s
Pharmaceutics: the design and manufacturing of
medicines. 3rd ed. Hungary: Harcourt publisher
ltd.; 2007. 175- 179.
Banker GS. Tablets. In: Lachman L, editors. The
theory and practice of industrial pharmacy. 3rd ed.
Mumbai, India: Varghese Publishing House;
296-303, 316-317.
Lalla JK, Gurnancy RA. Polymers for mucosal
delivery-swelling and mucoadhesive delivery.
Indian Drugs 2002; 39: 270-276
Grabovac V, Guggi D, Bernkop-Schnurch A.
Comparison of the mucoadhesive properties of
various polymers. Adv. Drug Deliv Reviews
; 57: 1713–1723.
Chavanpatil MD, Jain P, Chaudhari S, Shear
R, Vavia PR. Novel sustained release, swellable
and bioadhesive drug delivery system of
Ofloxacin. Int.J.Pharm, 2006; 316: 86-92
Ahuja S, Ahuja A, Baboota S, Ali J. Dissolution:
A promising tool in drug delivery. Indian J.
Pharm. Sci 2005; 67: 650-660.
Shah V. In vitro dissolution profile comparisonstatistics and analysis of the similarity factor, f2.
Pharmaceutical research 1998; 15: 889-896.
